Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trialResearch in context

Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trialResearch in context

Summary: Background: The need for oral, cost-effective treatment for complicated skin and skin structure infections (cSSSIs) due to methicillin-resistant Staphylococcus aureus (MRSA) was addressed by the non-inferiority comparisons of oral minocycline plus rifampicin with linezolid. Methods: In the...

Full description

Bibliographic Details
Main Authors: Antigone Kotsaki, Nikolaos Tziolos, Theano Kontopoulou, Ioannis M. Koutelidakis, Styliani Symbardi, Vaughan Reed, Miriam O'Hare, Zoi Alexiou, Helen Sambatakou, Konstantinos Toutouzas, Karolina Akinosoglou, Malvina Lada, Evangelos J. Giamarellos-Bourboulis, Alasdair MacGowan
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:EClinicalMedicine
Subjects:
Minocycline
Rifampicin
Linezolid
MRSA
Clincal trial
cSSI
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022005193

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022005193

Similar Items